INDEMNITY AGREEMENTIndemnity Agreement • November 24th, 2003 • Renovis Inc • Pharmaceutical preparations • Delaware
This Indemnity Agreement (“Agreement”) is made as of , 2003 by and between RENOVIS, INC., a Delaware corporation (the “Company”), and (“Indemnitee”).
SUBLEASESublease • November 24th, 2003 • Renovis Inc • Pharmaceutical preparations • California
THIS SUBLEASE (this “Sublease”) is dated for reference purposes as of October 31, 2003, and is made by and between Renovis, Inc., a Delaware corporation (“Sublandlord “), and KAI Pharmaceuticals, Inc., a Delaware corporation (“Subtenant”). Sublandlord and Subtenant agree as follows:
FIRST AMENDMENT TO SEPARATION AGREEMENTSeparation Agreement • November 24th, 2003 • Renovis Inc • Pharmaceutical preparations
This First Amendment to Separation Agreement (the “Agreement”) is made by and between Renovis, Inc. (hereinafter, the “Company”) and Dr. Lynne Zydowsky (“Zydowsky”) (together referred to as “the Parties”) and is entered into as of October 22, 2003, (the “Amendment Effective Date”). All of the capitalized terms not otherwise defined in this Agreement have the same respective meanings as contained in the Original Separation Agreement (defined below).
AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 24th, 2003 • Renovis Inc • Pharmaceutical preparations
THIS AMENDMENT TO ASSET PURCHASE AGREEMENT (the “Amendment”) is made and entered into effective as of October 23, 2002 (the “Amendment Effective Date”), by and between RENOVIS, INC., a Delaware corporation (“Purchaser”), and CENTAUR PHARMACEUTICALS, INC., a Delaware corporation (“Seller”). Purchaser and Seller may be referred to herein as a “Party” or, collectively, as “Parties”.
ASSET PURCHASE AGREEMENT between: CENTAUR PHARMACEUTICALS, INC., a Delaware corporation; and RENOVIS, INC., a Delaware corporationAsset Purchase Agreement • November 24th, 2003 • Renovis Inc • Pharmaceutical preparations • California
THIS ASSET PURCHASE AGREEMENT is entered into as of July 26, 2002, by and between: CENTAUR PHARMACEUTICALS, INC., a Delaware corporation (the “Seller”), and RENOVIS, INC., a Delaware corporation (the “Purchaser”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
